The campaign is among the largest anti-ICE protests by workers at a single company since federal agents shot and killed two people in Minneapolis last month. “We object to the technology we build ...

Can the two sides get past Iran’s claim that it has a “right” to enrich uranium? By Michael Crowley Reporting from Washington Zero. As the Trump administration begins negotiations with Iran to avoid ...

Syria’s state-owned Syrian Petroleum Company has signed a memorandum of understanding with US oil major Chevron International and Qatari firm UCC Holding to evaluate oil and gas exploration in Syrian ...

FRESNO, Calif. -- There's new hope for those looking to buy their first home in California. Later this month, the state will begin accepting applications for down payment assistance. It's part of the ...

The accidental distribution comes almost a year after the canned tuna products were originally recalled in February 2025 Sabrina Weiss is the Editorial Assistant of PEOPLE's food department. She ...

AirPods work most smoothly with Apple hardware, but they also connect reliably to Android phones, Windows laptops and other Bluetooth devices. The pairing process depends on the platform in use ...

Comedian Shane Gillis and his long-time collaborator John McKeever signed a multi-year deal with Netflix that will allow them to develop new projects for the streaming giant. The announcement comes as ...

Trump administration reps have just revealed a grandiose $112 billion plan to rebuild war-torn Gaza into a futuristic international destination dubbed “Project Sunrise.” The 10-year development plan, ...

Learn how to use advanced techniques like short-circuiting, parallel execution, virtual threads, and stream gatherers to maximize Java stream performance. My recent Java Stream API tutorial introduced ...

Addressing major unmet needs in mental health with pharmacology rooted in emerging and clinically validated neuropsychiatric biology Lead program ST-905, a potent M1/M4 muscarinic agonist, currently ...

Vivek Ramaswamy has found time out of his campaign for governor of Ohio to launch a new biotech. The new firm, Ambros Therapeutics, debuted Tuesday with a $125 million series A and plans to develop a ...

– New collaboration builds on Sanofi’s prior acquisition of DR-0201 and further leverages Dren Bio’s proprietary Targeted Myeloid Engager and Phagocytosis Platform to discover first-in-class ...